Methods | Six-week double-blind, randomised study. | |
Participants | Outpatients fulfilling DSM-III criteria for major depression (unipolar), with a score of at least 17 on the HDRS. Age range: 18-75 years. Exclusion criteria: significant pohysiacl illness, lactation, pregnancy, history of schizophrenia or drug or alcohol abuse, current use of antidepressant |
|
Interventions | Fluoxetine: 30 participants. Dothiepin: 30 participants. Fluoxetine dose range: 20-40 Dothiepine dose range: 100-200. Benzodiazepines were allowed for sedation at the discretion of the doctor |
|
Outcomes | Hamilton Rating Scale for Depression, Montgomery and Asberg Scale for Depression (MADRS), CGI Severity and Improvement, PGI | |
Notes | Funding: by industry | |
Risk of bias | ||
Item | Authors’ judgement | Description |
Allocation concealment? | Unclear | B - Unclear |